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 
Abstract— Implanted biomedical devices typically last a 
number of years before their batteries are depleted and a 
surgery is required to replace them. A Microbial Fuel Cell 
(MFC) is a device which by using bacteria, directly breaks 
down sugars to generate electricity. Conceptually there is 
potential to continually power implanted medical devices for 
the lifetime of a patient. To investigate the practical potential of 
this technology, H-Cell Dual Chamber MFCs were evaluated 
with two different growth solutions and measurements 
recorded for maximum power output both of individual MFCs 
and connected MFCs. Using Luria-Bertani media and 
connecting MFCs in a hybrid series and parallel arrangement 
with larger membrane sizes showed the highest power output 
and the greatest potential for replacing implanted batteries. 
I. INTRODUCTION 
Microbial Fuel Cell (MFC) technology has captured the 
fascination of many for their ability to use organic substrates 
such as sugar to directly generate electricity by means of 
bacteria. The standard dual chamber MFC (DCMFC) is 
composed of an anode and cathode chamber separated by a 
proton exchange membrane (PEM). In the anode chamber are 
bacteria, an anode electrode, a growth solution and sugar 
whilst in the cathode chamber is a cathode electrode and a 
chemical electron acceptor as illustrated in Fig. 1 [1, 2]. 
Figure 1. Microbial Fuel Cell Schematic 
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When a microbial population grows, the bacteria will 
reduce an electron acceptor such as oxygen. The anode 
electrode is the electron acceptor in a MFC, capturing the 
electrons, which travel through the electronic circuit and into 
the cathode chamber via the cathode electrode. The electron 
is then removed from the electrode by some chemical 
electron acceptor. In a basic MFC, the bacteria also outputs 
hydrogen, which travels to the cathode chamber by diffusing 
through the membrane. Dissolved oxygen in the cathode 
chamber will link up with the hydrogen and electron to 
remove the oxygen and create water [1, 2]. 
Pacemakers and other implanted biomedical devices 
typically require approximately 30µW of power whilst other 
devices such as the artificial urinary sphincter are more 
demanding, requiring 200µW of power [3, 4]. Once all the 
power is consumed from the battery, surgery is required to 
replace the power source. Surgery is not the preferred option 
as there is an inherent risk to patients who are already in poor 
health. Radio Frequency charging through the skin has 
undergone several developments, but heating of the skin is 
still a major issue coupled with prolong periods of charging 
[3]. Movement is usually required of the user for kinetic 
energy harvesting systems, solar cells cannot be implanted 
and maintaining temperature gradients for thermal energy 
harvesting is difficult. Parts of the body have well regulated 
levels of glucose and oxygen which could replenish a MFC. 
This source of energy could potentially drive a MFC far 
beyond a normal battery.  
Many MFC studies have focused on their use in 
biomedical applications; however more research is required 
to fully realized this potential [5-8]. In these studies, bodily 
fluids are often used within the MFC; however this is most 
likely to cause disruption, possible infection and rejection of 
the implant within the patient. Previous work by Roxby et al 
has also shown that a single MFC cannot provide sufficient 
voltage to operate a biomedical device [9, 10]. In this study, 
we focused on Luria-Bertani (LB) broth and Tryptic Soy 
Broth (TSB) to optimize power output in single self-
contained MFC or multiple arranged MFCs. Additionally we 
also investigated the effect of two different membrane sizes 
(25 mm and 40 mm) on the MFC output [11]. 
II. EXPERIMENTAL METHOD
A. Microbe and Growth Conditions 
Laboratory stocks of Shewanella oneidensis MR-1 were 
chosen as the inoculate for our experiments for its 
exoelectrogenic capabilities and was originally purchased 
from the American Type Culture Collection (ATCC 700500) 
[12]. A Tryptic Soy Agar plate was streaked from laboratory 
stocks and grown for the standard overnight period (16 to 18 
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hours) in a 30°C incubator. From this, a single colony was 
picked and placed in to 50mL of Tryptic Soy Broth (TSB) in 
a 200mL Erlenmeyer flask and shaking incubated for the 
overnight period at 30°C and 200 R.P.M. Each DCMFC was 
inoculated with 100µL of cells into the DCMFC anode. CFU 
counts were tested to be within 1 to 10 x 10
8
 CFU/mL with 
the drop plating method. 
B. MFC Materials 
Autoclaved (121°C, 20 minutes) H-Cell MFCs purchased 
from Adam’s Chittenden Scientific glassware contained 100 
mL of either TSB or LB broth as the anolyte and 100 mL of 
Phosphate Buffer Solution (PBS) at pH 7.0 as the catholyte. 
Nafion-117 with diameters of 25 mm and 40 mm were used 
as the separating membrane. The electrodes were Reticulated 
Vitreous Carbon (RVC) of 30 mm x 30 mm x 0.5 mm size, 
having an approximate surface area of 0.02775 m
2
 
(Goodfellow Corp.). Titanium wire of diameter 0.5 mm 
insulated with heat shrink tubing was used in twisted pair 
along with conductive silver epoxy to connect the wire to the 
electrodes (CircuitWorks CW2400). The assembled wire 
with electrodes and membrane were exposed to UV for 10 
minutes on each side for sterilization purposes. 
C. Measurement Setup 
During the first 6 to 7 days of MFC operation, the open 
circuit voltage of the MFCs were logged every 10 seconds, 
and then polarization curves were taken with resistors 
connected at 3.9MΩ followed by a stepping down in 
resistance until the voltage equaled zero. With each change, 
the voltage was left to stabilize for at least 10 minutes and 
then the voltage measured. Measurements were taken with a 
National Instruments USB-6009 connected to a Windows PC 
with a custom LabView program in differential measurement 
mode. Output current was calculated by Ohm’s law (V = IR). 
Area and volumetric maximum current and power output are 
referred to the electrode surface area and total combined 
chamber volume respectively. For each LB and TSB 
experiment, MFCs were run in triplicate in the same 
environment at room temperature and each set of MFCs were 
inoculated from the same overnight culture. 
 
Figure 2. MFC Array connections. (a) Parallel, (b) Series (c) Hybrid 
Parallel-Series 
C. Arrays of DCMFCs 
After running four LB DCMFCs for the 6 to 7 day period, 
then conducting the individual polarization and power curves 
with them, the DCMFCs were connected in the arrays shown 
in Fig. 2 where further polarization and power curves data 
were taken by the method described in the previous section. 
The MFCs were left in open circuit for 24 hours between 
array experiments to permit voltage recovery. 
III. RESULTS AND DISCUSSION 
To test self-contained MFCs that would not rely on the 
human body and were separate from it, TSB and LB 
DCMFCs were tested. During these tests, the MFCs were left 
firstly in open circuit for approximately 6 to 7 days which 
allowed a microbial population and voltage to develop. To 
test their ability to deal with an electrical load, various 
resistances were connected and the power calculated. 
Following this, to further test the potential to turn on a 
device, arrays of DCMFCs were setup and their voltage 
monitored after various resistances were connected.  
The voltages developed in open circuit mode for both the 
LB and TSB DCMFCs over a 6 to 7 day period are shown in 
Fig. 3. During the running of the LB MFC, the peak voltage 
reached was 464.557 mV and occurred on the sixth day of the 
running of the MFC. This is compared to a peak voltage of 
332.86 mV occurring again on the sixth day for the TSB 
MFC.  
In the first two days of the running of the MFC 
experiments, the TSB voltage increased by approximately 
200 mV in the first day, whilst the LB MFC’s voltage 
increased from the second day by approximately the same 
amount. The TSB voltage was mostly stable by the second 
day onwards, whilst the LB voltage seemed to continue to 
increase until it leveled off in the final day.  
B. TSB and LB Polarization and Power Curves 
The polarization curves for the TSB and LB MFCs are 
shown in Fig. 4. For the TSB MFC, the values ranged from 
451.02 mV at 0.115 µA to 70.8 mV at 70.8µA. This is in 
comparison to 328.82 mV at 0.084 µA to 13.42 mV at 16.37 
µA. The S. oneidensis MR-1 population grown from LB is 
clearly better able to support a higher voltage and current 
than that grown by the TSB.  
Fig. 5. shows the power curves for the LB and TSB 
MFCs taken after the 6 to 7 day open circuit growth period. 
The peak power for the TSB DCMFC was found to 
 
Figure 3. LB and TSB Voltages for open circuit DCMFCs over 6 to 7 days 
  
 
Figure 4. Polarization Curves for LB and TSB DCMFCs after various 
resistances were connected 
be 1.23 mW at 11 µA which was almost 8 times lower than 
the LB MFC peak power of 9.68 mW at 34.31 µA. Since the 
peak power occurs when the internal and external resistance 
are matched, the internal resistance for the TSB MFC is 
10000 Ω and for the LB DCMFC is 8200 Ω. Since there is 
minimal difference between the resistances, the difference in 
MFC output may be coming purely from the bacteria and the 
growth media, since all other components of the system 
remain the same. 
This is a good result in terms of potential for MFC 
technology to power implanted biomedical devices since 
pacemakers can operate off approximately 30 µW. At this 
stage though, from individual DCMFCs, it is not possible 
since the voltage is too low to be able to turn on a device. 
One possibility to accommodate this lies in the use of a DC-
DC converter. A LTC3109 Evaluation Board was connected 
to the LB DCMFCs and the voltage collapsed. 5V was 
measured at the output of the Evaluation Board, however 
when a LED was connected, no light could be seen, possibly 
due to the need for a higher current. 
C. Comparison of Different Membrane Sizes in DCMFCs 
One of the many aspects of a MFC is its structural design, 
which would impact on the chemical dynamics within the 
reactor. To further understand the impact that the membrane 
size structural design of DCMFCs has on the MFC output, 
two different membrane sizes were used in the LB MFCs. LB 
was chosen as the media here since it was the better 
performing of the growth media. 
Fig. 7 shows the polarization curves for the 25 mm and 
40 mm. The voltage is overall higher for the larger  
  
Figure 5. Power Curves for LB and TSB DCMFCs after various resistances 
were connected  
 
Figure 6. Polarization Curve for LB DCMFCs with 25 mm and 40 mm 
membrane sizes 
membrane, giving an average of 304.28 mV, whilst for the 
small membrane the average voltage was 286.73 mV. The 
results for the power curve follow this trend, showing that the 
peak power from the 40 mm membrane MFC is 9.68 mW 
whilst for the 25 mm membrane MFC is was 5.94 mW. This 
represents 1.6 fold increase in power by simply designing for 
a larger membrane size and is perhaps due to a greater area 
for the hydrogen to flow through the membrane to complete 
the reaction in the cathode chamber. 
D. Polarization and Voltage Curves of Arrays of MFCs 
To test what the effect of connecting several MFCs 
together in different configurations may have on the voltage 
and current output, 4 LB MFCs were connected together and 
polarization and power curves were taken and shown in Fig. 
8 and Fig. 9 respectively.  In the two curves, the results are 
what are expected when connecting several power sources 
together.  
For the series connected array, the voltage is higher, 
starting at approximately 4 times the individual MFC at 
1619.38 mV at 0.45 µA and ranged down to 33.92 mV at 
66.51 µA. In the parallel connected array, the voltage began 
at 490.56 mV at 0.257 µA and ranged down to 102.105 mV 
at 378.17 µA which is approximately 4 times the current 
output of an individual DCMFC. Lastly, in the Parallel-Series 
connected setup designated by ‘PS’, the maximum and 
minimum voltage and current are approximately midway 
between the series and parallel setups ranging from 913 mV 
at 0.23 µA to 70.71 mV at 261.89 µA.  
 




Figure 8. Polarization Curve for MFC Arrays 
The series array in the power curve seemed to provide the 
least power, giving a peak of 39.07 mW at 51.04 µA, the 
parallel array gave a peak of 63.47 mW at 251.94 µA and 
again the PS setup gave a midway between the series and 
parallel setups at 54.64 mW at 103.51 µA. The respective 
internal resistances were 15000 Ω, 1000 Ω and 5100 Ω for 
the various connected arrays and are expected when 
connecting resistances in this way, except in the case of the 
series connection where it appears lower. 
Our results further indicate the potential to power 
implanted biomedical devices using bacteria. In each of the 
connections, the power is sufficient to operate electrical 
devices. The parallel result demonstrates that adding 
DCMFCs together can increase the current over a single 
DCMFC, whilst the series connection shows that by adding 
DCMFCs provides greater voltage. The hybrid series-parallel 
connection allows for increases in both. Further work could 
investigate these setups in longer term experiments. 
IV.  CONCLUSION 
If MFCs are to be implantable, to avoid infection of the 
patient, they will need to be able to contain the bacteria from 
the body. A self-contained MFC then is required and in this 
study, we show that a LB MFC has the potential to fulfill 
these criteria. LB also showed a 7.9 fold increase in power 
over a TSB MFC. 
Despite the increases in power between the two growth 
media, one MFC is not enough to turn on electronic devices 
due to the low current and voltage. Interestingly by 
increasing the size of the membrane from 25 mm to 40 mm, a 
current increase of 1.6 fold was observed. To increase the 
voltage, several MFCs were connected in different arrays. 
The series connected array increased the voltage, but could 
not achieve a high power. The parallel connection gave high 
current output but a low voltage. In contrast, the hybrid 
series-parallel connection had increases in both the voltage 
and current. 
Whilst there is much potential for MFCs to power 
implanted biomedical devices, there are many challenges 
ahead. The laboratory based MFCs, despite using a self-
contained approach, would still need significant work to be 
safe to be implanted inside the human body. Further work 
could address the longevity and stability of these MFCs. 
Additionally, if MFCs are connected in an array long term, 
the electrochemical environment may not suit the bacteria. 
 
Figure 9. Power Curve for MFC Arrays 
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